Literature DB >> 14752792

Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia.

Christopher C Porter1, Kathryn M Edwards, Yuwei Zhu, Haydar Frangoul.   

Abstract

PURPOSE: To compare the immune responses to influenza vaccine in children with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy with those in healthy children.
METHODS: Hemagglutinin-inhibition (HAI) antibody titers were determined before and after influenza vaccination in children with ALL and healthy controls. Immune responses were measured as geometric mean titers (GMT) and 4-fold rises in HAI titers.
RESULTS: Although post-immunization GMT were lower in children with ALL compared to healthy children for the H1N1 antigen (P<0.001), the H3N2 antigen (P=0.03), and for the influenza B antigen (P=0.003), at least 60% of children with ALL had at least a 4-fold rise in HAI titers to each of the influenza antigens.
CONCLUSIONS: While the GMT after trivalent influenza immunization in children with ALL were significantly lower than those seen in healthy children, the majority of children with ALL had 4-fold rises in HAI titers. Children receiving maintenance chemotherapy for ALL should receive yearly influenza vaccine. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752792     DOI: 10.1002/pbc.10459

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients.

Authors:  Carrye Cost; Evangeline Brock; Beverley Adams-Huet; Jane D Siegel; Monica I Ardura
Journal:  Pediatr Blood Cancer       Date:  2011-01       Impact factor: 3.167

Review 2.  Influenza vaccination in children being treated with chemotherapy for cancer.

Authors:  Ginette M Goossen; Leontien C M Kremer; Marianne D van de Wetering
Journal:  Cochrane Database Syst Rev       Date:  2013-08-01

3.  Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies.

Authors:  Yuichiro Ide; Yutaka Imamura; Satoko Ohfuji; Wakaba Fukushima; Saburo Ide; Chiyo Tsutsumi; Masahisa Koga; Kazuhiro Maeda; Yoshio Hirota
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation.

Authors:  Avinash K Shetty; Mary A Winter
Journal:  Ochsner J       Date:  2012

Review 5.  Protecting pediatric oncology patients from influenza.

Authors:  Leslie S Kersun; Anne F Reilly; Susan E Coffin; Kathleen E Sullivan
Journal:  Oncologist       Date:  2013-01-31

6.  Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.

Authors:  Hana Hakim; Kim J Allison; Lee-Ann Van de Velde; Li Tang; Yilun Sun; Patricia M Flynn; Jonathan A McCullers
Journal:  Vaccine       Date:  2016-04-26       Impact factor: 3.641

7.  A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings.

Authors:  Rebecca Pellett Madan; Maria Tan; Ana Fernandez-Sesma; Thomas M Moran; Sukru Emre; Andrew Campbell; Betsy C Herold
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

8.  Adult Acute Myeloid Leukemia Long-term Survivors.

Authors:  M Jennifer Cheng; Christopher S Hourigan; Thomas J Smith
Journal:  J Leuk (Los Angel)       Date:  2014-04-10

Review 9.  Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.

Authors:  Charles R Beck; Bruce C McKenzie; Ahmed B Hashim; Rebecca C Harris; Arina Zanuzdana; Gabriel Agboado; Elizabeth Orton; Laura Béchard-Evans; Gemma Morgan; Charlotte Stevenson; Rachel Weston; Mitsuru Mukaigawara; Joanne Enstone; Glenda Augustine; Mobasher Butt; Sophie Kim; Richard Puleston; Girija Dabke; Robert Howard; Julie O'Boyle; Mary O'Brien; Lauren Ahyow; Helene Denness; Siobhan Farmer; Jose Figureroa; Paul Fisher; Felix Greaves; Munib Haroon; Sophie Haroon; Caroline Hird; Rachel Isba; David A Ishola; Marko Kerac; Vivienne Parish; Jonathan Roberts; Julia Rosser; Sarah Theaker; Dean Wallace; Neil Wigglesworth; Liz Lingard; Yana Vinogradova; Hiroshi Horiuchi; Javier Peñalver; Jonathan S Nguyen-Van-Tam
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

Review 10.  Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation.

Authors:  Brian T Fisher; Sarah Alexander; Christopher C Dvorak; Theoklis E Zaoutis; Danielle M Zerr; Lillian Sung
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.